nodes	percent_of_prediction	percent_of_DWPC	metapath
Lithium—schizophrenia—Cyproheptadine—allergic rhinitis	0.286	0.363	CpDpCtD
Lithium—schizophrenia—Dimenhydrinate—allergic rhinitis	0.286	0.363	CpDpCtD
Lithium—schizophrenia—Diphenhydramine—allergic rhinitis	0.217	0.275	CpDpCtD
Lithium—IMPA2—respiratory system—allergic rhinitis	0.00482	0.103	CbGeAlD
Lithium—GSK3B—respiratory system—allergic rhinitis	0.00473	0.101	CbGeAlD
Lithium—GSK3B—eye—allergic rhinitis	0.00432	0.0927	CbGeAlD
Lithium—IMPA2—bronchus—allergic rhinitis	0.00397	0.0851	CbGeAlD
Lithium—GSK3B—epithelium—allergic rhinitis	0.00395	0.0848	CbGeAlD
Lithium—IMPA2—skin of body—allergic rhinitis	0.00383	0.0822	CbGeAlD
Lithium—GSK3A—eye—allergic rhinitis	0.00376	0.0806	CbGeAlD
Lithium—IMPA2—trachea—allergic rhinitis	0.00356	0.0764	CbGeAlD
Lithium—GSK3A—bronchus—allergic rhinitis	0.00339	0.0726	CbGeAlD
Lithium—GSK3A—trachea—allergic rhinitis	0.00304	0.0652	CbGeAlD
Lithium—IMPA2—lung—allergic rhinitis	0.00256	0.0549	CbGeAlD
Lithium—GSK3B—lung—allergic rhinitis	0.00251	0.0539	CbGeAlD
Lithium—GSK3A—lung—allergic rhinitis	0.00218	0.0468	CbGeAlD
Lithium—GSK3B—IL17 signaling pathway—IL17A—allergic rhinitis	0.00131	0.0635	CbGpPWpGaD
Lithium—GSK3A—Fc epsilon receptor (FCERI) signaling—MS4A2—allergic rhinitis	0.000937	0.0455	CbGpPWpGaD
Lithium—GSK3B—Axon guidance—PFN2—allergic rhinitis	0.000743	0.0361	CbGpPWpGaD
Lithium—GSK3B—Fc epsilon receptor (FCERI) signaling—MS4A2—allergic rhinitis	0.000692	0.0336	CbGpPWpGaD
Lithium—GSK3B—Glucocorticoid receptor regulatory network—IL13—allergic rhinitis	0.000652	0.0317	CbGpPWpGaD
Lithium—GSK3A—T-Cell Receptor and Co-stimulatory Signaling—NFKB1—allergic rhinitis	0.00062	0.0301	CbGpPWpGaD
Lithium—GSK3B—Glucocorticoid receptor regulatory network—IL5—allergic rhinitis	0.000558	0.0271	CbGpPWpGaD
Lithium—GSK3B—Developmental Biology—PFN2—allergic rhinitis	0.00053	0.0258	CbGpPWpGaD
Lithium—GSK3B—T-Cell Receptor and Co-stimulatory Signaling—NFKB1—allergic rhinitis	0.000458	0.0223	CbGpPWpGaD
Lithium—GSK3B—Melatonin metabolism and effects—NFKB1—allergic rhinitis	0.000458	0.0223	CbGpPWpGaD
Lithium—IMPA1—Integrated Breast Cancer Pathway—NFKB1—allergic rhinitis	0.00044	0.0214	CbGpPWpGaD
Lithium—GSK3B—IL17 signaling pathway—NFKB1—allergic rhinitis	0.000434	0.0211	CbGpPWpGaD
Lithium—GSK3B—Glucocorticoid receptor regulatory network—IL4—allergic rhinitis	0.000397	0.0193	CbGpPWpGaD
Lithium—GSK3B—Androgen receptor signaling pathway—SMAD3—allergic rhinitis	0.000368	0.0179	CbGpPWpGaD
Lithium—GSK3A—Innate Immune System—MS4A2—allergic rhinitis	0.000364	0.0177	CbGpPWpGaD
Lithium—GSK3B—TWEAK Signaling Pathway—NFKB1—allergic rhinitis	0.000341	0.0166	CbGpPWpGaD
Lithium—GSK3B—Hair Follicle Development: Induction (Part 1 of 3)—NFKB1—allergic rhinitis	0.000341	0.0166	CbGpPWpGaD
Lithium—GSK3B—Cell Cycle—SMAD3—allergic rhinitis	0.00033	0.016	CbGpPWpGaD
Lithium—GSK3B—Senescence and Autophagy in Cancer—SMAD3—allergic rhinitis	0.000322	0.0157	CbGpPWpGaD
Lithium—GSK3B—Glucocorticoid receptor regulatory network—ICAM1—allergic rhinitis	0.000315	0.0153	CbGpPWpGaD
Lithium—GSK3B—DNA Damage Response (only ATM dependent)—SMAD3—allergic rhinitis	0.000313	0.0152	CbGpPWpGaD
Lithium—GSK3A—Leptin signaling pathway—NFKB1—allergic rhinitis	0.00029	0.0141	CbGpPWpGaD
Lithium—GSK3B—Cardiac Hypertrophic Response—NFKB1—allergic rhinitis	0.000275	0.0133	CbGpPWpGaD
Lithium—GSK3B—Innate Immune System—MS4A2—allergic rhinitis	0.000269	0.0131	CbGpPWpGaD
Lithium—GSK3B—Circadian rythm related genes—ADIPOQ—allergic rhinitis	0.000264	0.0128	CbGpPWpGaD
Lithium—GSK3B—Notch Signaling Pathway—NFKB1—allergic rhinitis	0.000253	0.0123	CbGpPWpGaD
Lithium—GSK3B—LPA receptor mediated events—NFKB1—allergic rhinitis	0.000243	0.0118	CbGpPWpGaD
Lithium—GRIA3—BDNF signaling pathway—NFKB1—allergic rhinitis	0.00024	0.0117	CbGpPWpGaD
Lithium—GSK3A—B Cell Receptor Signaling Pathway—NFKB1—allergic rhinitis	0.000236	0.0115	CbGpPWpGaD
Lithium—GSK3B—Cardiac Progenitor Differentiation—TGFB1—allergic rhinitis	0.000236	0.0115	CbGpPWpGaD
Lithium—GSK3B—Cardiac Hypertrophic Response—TGFB1—allergic rhinitis	0.000229	0.0111	CbGpPWpGaD
Lithium—GSK3B—Leptin signaling pathway—NFKB1—allergic rhinitis	0.000214	0.0104	CbGpPWpGaD
Lithium—GSK3A—Immune System—MS4A2—allergic rhinitis	0.000212	0.0103	CbGpPWpGaD
Lithium—GSK3B—Glucocorticoid receptor regulatory network—NFKB1—allergic rhinitis	0.000199	0.0097	CbGpPWpGaD
Lithium—Dyspepsia—Cetirizine—allergic rhinitis	0.000197	0.00136	CcSEcCtD
Lithium—Vomiting—Dimenhydrinate—allergic rhinitis	0.000196	0.00136	CcSEcCtD
Lithium—Vomiting—Diphenhydramine—allergic rhinitis	0.000196	0.00136	CcSEcCtD
Lithium—Feeling abnormal—Loratadine—allergic rhinitis	0.000196	0.00135	CcSEcCtD
Lithium—GSK3B—MicroRNAs in cardiomyocyte hypertrophy—NFKB1—allergic rhinitis	0.000196	0.00951	CbGpPWpGaD
Lithium—Arthralgia—Montelukast—allergic rhinitis	0.000196	0.00135	CcSEcCtD
Lithium—Rash—Diphenhydramine—allergic rhinitis	0.000195	0.00134	CcSEcCtD
Lithium—Rash—Dimenhydrinate—allergic rhinitis	0.000195	0.00134	CcSEcCtD
Lithium—Decreased appetite—Cetirizine—allergic rhinitis	0.000194	0.00134	CcSEcCtD
Lithium—Dermatitis—Dimenhydrinate—allergic rhinitis	0.000194	0.00134	CcSEcCtD
Lithium—Dermatitis—Diphenhydramine—allergic rhinitis	0.000194	0.00134	CcSEcCtD
Lithium—Gastrointestinal pain—Loratadine—allergic rhinitis	0.000194	0.00134	CcSEcCtD
Lithium—Dyspepsia—Flunisolide—allergic rhinitis	0.000194	0.00134	CcSEcCtD
Lithium—Dry skin—Prednisolone—allergic rhinitis	0.000193	0.00134	CcSEcCtD
Lithium—Headache—Diphenhydramine—allergic rhinitis	0.000193	0.00134	CcSEcCtD
Lithium—Headache—Dimenhydrinate—allergic rhinitis	0.000193	0.00134	CcSEcCtD
Lithium—Fatigue—Cetirizine—allergic rhinitis	0.000193	0.00133	CcSEcCtD
Lithium—Decreased appetite—Flunisolide—allergic rhinitis	0.000191	0.00132	CcSEcCtD
Lithium—Fatigue—Flunisolide—allergic rhinitis	0.00019	0.00131	CcSEcCtD
Lithium—Dry skin—Hydrocortisone—allergic rhinitis	0.000189	0.00131	CcSEcCtD
Lithium—GSK3A—Adaptive Immune System—HLA-G—allergic rhinitis	0.000189	0.00917	CbGpPWpGaD
Lithium—Body temperature increased—Loratadine—allergic rhinitis	0.000188	0.0013	CcSEcCtD
Lithium—Abdominal pain—Loratadine—allergic rhinitis	0.000188	0.0013	CcSEcCtD
Lithium—Oedema—Montelukast—allergic rhinitis	0.000187	0.0013	CcSEcCtD
Lithium—Nausea—Olopatadine—allergic rhinitis	0.000187	0.00129	CcSEcCtD
Lithium—Muscular weakness—Prednisolone—allergic rhinitis	0.000186	0.00129	CcSEcCtD
Lithium—Feeling abnormal—Cetirizine—allergic rhinitis	0.000184	0.00127	CcSEcCtD
Lithium—Nausea—Dimenhydrinate—allergic rhinitis	0.000183	0.00127	CcSEcCtD
Lithium—Nausea—Diphenhydramine—allergic rhinitis	0.000183	0.00127	CcSEcCtD
Lithium—Gastrointestinal pain—Cetirizine—allergic rhinitis	0.000183	0.00126	CcSEcCtD
Lithium—GSK3B—Corticotropin-releasing hormone—NFKB1—allergic rhinitis	0.000182	0.00884	CbGpPWpGaD
Lithium—Muscular weakness—Hydrocortisone—allergic rhinitis	0.000182	0.00126	CcSEcCtD
Lithium—Feeling abnormal—Flunisolide—allergic rhinitis	0.000181	0.00125	CcSEcCtD
Lithium—Gastrointestinal pain—Flunisolide—allergic rhinitis	0.00018	0.00124	CcSEcCtD
Lithium—Lethargy—Betamethasone—allergic rhinitis	0.00018	0.00124	CcSEcCtD
Lithium—Lethargy—Dexamethasone—allergic rhinitis	0.00018	0.00124	CcSEcCtD
Lithium—Body temperature increased—Cetirizine—allergic rhinitis	0.000177	0.00122	CcSEcCtD
Lithium—Abdominal pain—Cetirizine—allergic rhinitis	0.000177	0.00122	CcSEcCtD
Lithium—GSK3B—B Cell Receptor Signaling Pathway—NFKB1—allergic rhinitis	0.000174	0.00848	CbGpPWpGaD
Lithium—Abdominal pain—Flunisolide—allergic rhinitis	0.000174	0.0012	CcSEcCtD
Lithium—Body temperature increased—Flunisolide—allergic rhinitis	0.000174	0.0012	CcSEcCtD
Lithium—Muscular weakness—Triamcinolone—allergic rhinitis	0.000171	0.00118	CcSEcCtD
Lithium—Musculoskeletal discomfort—Montelukast—allergic rhinitis	0.000171	0.00118	CcSEcCtD
Lithium—Muscular weakness—Methylprednisolone—allergic rhinitis	0.000171	0.00118	CcSEcCtD
Lithium—Asthenia—Loratadine—allergic rhinitis	0.00017	0.00118	CcSEcCtD
Lithium—GSK3B—Neural Crest Differentiation—NFKB1—allergic rhinitis	0.000169	0.00821	CbGpPWpGaD
Lithium—Somnolence—Montelukast—allergic rhinitis	0.000167	0.00115	CcSEcCtD
Lithium—Weight increased—Prednisolone—allergic rhinitis	0.000166	0.00115	CcSEcCtD
Lithium—GSK3A—Integrated Breast Cancer Pathway—NFKB1—allergic rhinitis	0.000166	0.00805	CbGpPWpGaD
Lithium—Dyspepsia—Montelukast—allergic rhinitis	0.000165	0.00114	CcSEcCtD
Lithium—GSK3B—MicroRNAs in cardiomyocyte hypertrophy—TGFB1—allergic rhinitis	0.000163	0.00792	CbGpPWpGaD
Lithium—Diarrhoea—Loratadine—allergic rhinitis	0.000163	0.00112	CcSEcCtD
Lithium—Weight increased—Hydrocortisone—allergic rhinitis	0.000162	0.00112	CcSEcCtD
Lithium—Fatigue—Montelukast—allergic rhinitis	0.000162	0.00112	CcSEcCtD
Lithium—Dry skin—Betamethasone—allergic rhinitis	0.000161	0.00112	CcSEcCtD
Lithium—Dry skin—Dexamethasone—allergic rhinitis	0.000161	0.00112	CcSEcCtD
Lithium—Weight decreased—Hydrocortisone—allergic rhinitis	0.000161	0.00111	CcSEcCtD
Lithium—Asthenia—Cetirizine—allergic rhinitis	0.00016	0.00111	CcSEcCtD
Lithium—GSK3B—DNA Damage Response (only ATM dependent)—NFKB1—allergic rhinitis	0.000159	0.00772	CbGpPWpGaD
Lithium—Asthenia—Flunisolide—allergic rhinitis	0.000158	0.00109	CcSEcCtD
Lithium—Dizziness—Loratadine—allergic rhinitis	0.000157	0.00109	CcSEcCtD
Lithium—GSK3B—Immune System—MS4A2—allergic rhinitis	0.000157	0.00761	CbGpPWpGaD
Lithium—Muscular weakness—Dexamethasone—allergic rhinitis	0.000155	0.00107	CcSEcCtD
Lithium—Muscular weakness—Betamethasone—allergic rhinitis	0.000155	0.00107	CcSEcCtD
Lithium—Gastrointestinal pain—Montelukast—allergic rhinitis	0.000153	0.00106	CcSEcCtD
Lithium—Diarrhoea—Cetirizine—allergic rhinitis	0.000153	0.00106	CcSEcCtD
Lithium—GSK3A—Downstream signaling events of B Cell Receptor (BCR)—NFKB1—allergic rhinitis	0.000153	0.00743	CbGpPWpGaD
Lithium—Weight increased—Triamcinolone—allergic rhinitis	0.000153	0.00105	CcSEcCtD
Lithium—Weight increased—Methylprednisolone—allergic rhinitis	0.000152	0.00105	CcSEcCtD
Lithium—GSK3B—Corticotropin-releasing hormone—TGFB1—allergic rhinitis	0.000152	0.00737	CbGpPWpGaD
Lithium—Vomiting—Loratadine—allergic rhinitis	0.000151	0.00104	CcSEcCtD
Lithium—Diarrhoea—Flunisolide—allergic rhinitis	0.00015	0.00104	CcSEcCtD
Lithium—Rash—Loratadine—allergic rhinitis	0.00015	0.00104	CcSEcCtD
Lithium—Dermatitis—Loratadine—allergic rhinitis	0.00015	0.00103	CcSEcCtD
Lithium—Headache—Loratadine—allergic rhinitis	0.000149	0.00103	CcSEcCtD
Lithium—Bradycardia—Prednisolone—allergic rhinitis	0.000149	0.00103	CcSEcCtD
Lithium—Abdominal pain—Montelukast—allergic rhinitis	0.000148	0.00102	CcSEcCtD
Lithium—Body temperature increased—Montelukast—allergic rhinitis	0.000148	0.00102	CcSEcCtD
Lithium—Dizziness—Cetirizine—allergic rhinitis	0.000148	0.00102	CcSEcCtD
Lithium—GSK3A—Fc epsilon receptor (FCERI) signaling—NFKB1—allergic rhinitis	0.000146	0.00709	CbGpPWpGaD
Lithium—Dizziness—Flunisolide—allergic rhinitis	0.000145	0.001	CcSEcCtD
Lithium—Bradycardia—Hydrocortisone—allergic rhinitis	0.000145	0.001	CcSEcCtD
Lithium—Vomiting—Cetirizine—allergic rhinitis	0.000142	0.000983	CcSEcCtD
Lithium—Hallucination—Hydrocortisone—allergic rhinitis	0.000142	0.00098	CcSEcCtD
Lithium—Nausea—Loratadine—allergic rhinitis	0.000141	0.000976	CcSEcCtD
Lithium—Rash—Cetirizine—allergic rhinitis	0.000141	0.000975	CcSEcCtD
Lithium—Dermatitis—Cetirizine—allergic rhinitis	0.000141	0.000974	CcSEcCtD
Lithium—Headache—Cetirizine—allergic rhinitis	0.00014	0.000968	CcSEcCtD
Lithium—Vomiting—Flunisolide—allergic rhinitis	0.00014	0.000966	CcSEcCtD
Lithium—GSK3B—Cell Cycle—TGFB1—allergic rhinitis	0.00014	0.00678	CbGpPWpGaD
Lithium—GSK3B—Adaptive Immune System—HLA-G—allergic rhinitis	0.000139	0.00678	CbGpPWpGaD
Lithium—Rash—Flunisolide—allergic rhinitis	0.000139	0.000958	CcSEcCtD
Lithium—Dermatitis—Flunisolide—allergic rhinitis	0.000138	0.000957	CcSEcCtD
Lithium—Weight increased—Dexamethasone—allergic rhinitis	0.000138	0.000957	CcSEcCtD
Lithium—Weight increased—Betamethasone—allergic rhinitis	0.000138	0.000957	CcSEcCtD
Lithium—Headache—Flunisolide—allergic rhinitis	0.000138	0.000952	CcSEcCtD
Lithium—Weight decreased—Dexamethasone—allergic rhinitis	0.000138	0.000951	CcSEcCtD
Lithium—Weight decreased—Betamethasone—allergic rhinitis	0.000138	0.000951	CcSEcCtD
Lithium—GSK3A—Integrated Pancreatic Cancer Pathway—NFKB1—allergic rhinitis	0.000137	0.00667	CbGpPWpGaD
Lithium—Hyperglycaemia—Betamethasone—allergic rhinitis	0.000137	0.000949	CcSEcCtD
Lithium—Hyperglycaemia—Dexamethasone—allergic rhinitis	0.000137	0.000949	CcSEcCtD
Lithium—Bradycardia—Triamcinolone—allergic rhinitis	0.000137	0.000944	CcSEcCtD
Lithium—GSK3B—Senescence and Autophagy in Cancer—TGFB1—allergic rhinitis	0.000136	0.00663	CbGpPWpGaD
Lithium—Bradycardia—Methylprednisolone—allergic rhinitis	0.000136	0.000942	CcSEcCtD
Lithium—GSK3A—B Cell Activation—NFKB1—allergic rhinitis	0.000135	0.00656	CbGpPWpGaD
Lithium—Asthenia—Montelukast—allergic rhinitis	0.000135	0.00093	CcSEcCtD
Lithium—Hallucination—Methylprednisolone—allergic rhinitis	0.000133	0.000921	CcSEcCtD
Lithium—Nausea—Cetirizine—allergic rhinitis	0.000133	0.000918	CcSEcCtD
Lithium—GSK3B—DNA Damage Response (only ATM dependent)—TGFB1—allergic rhinitis	0.000132	0.00643	CbGpPWpGaD
Lithium—Nausea—Flunisolide—allergic rhinitis	0.000131	0.000903	CcSEcCtD
Lithium—Arrhythmia—Prednisolone—allergic rhinitis	0.00013	0.000901	CcSEcCtD
Lithium—GSK3B—Developmental Biology—ADIPOQ—allergic rhinitis	0.000128	0.00624	CbGpPWpGaD
Lithium—Diarrhoea—Montelukast—allergic rhinitis	0.000128	0.000887	CcSEcCtD
Lithium—Arrhythmia—Hydrocortisone—allergic rhinitis	0.000127	0.00088	CcSEcCtD
Lithium—GSK3B—BDNF signaling pathway—NFKB1—allergic rhinitis	0.000127	0.00618	CbGpPWpGaD
Lithium—Dizziness—Montelukast—allergic rhinitis	0.000124	0.000857	CcSEcCtD
Lithium—Bradycardia—Dexamethasone—allergic rhinitis	0.000124	0.000857	CcSEcCtD
Lithium—Bradycardia—Betamethasone—allergic rhinitis	0.000124	0.000857	CcSEcCtD
Lithium—Hallucination—Dexamethasone—allergic rhinitis	0.000121	0.000837	CcSEcCtD
Lithium—Hallucination—Betamethasone—allergic rhinitis	0.000121	0.000837	CcSEcCtD
Lithium—Arrhythmia—Triamcinolone—allergic rhinitis	0.00012	0.000829	CcSEcCtD
Lithium—Vision blurred—Prednisolone—allergic rhinitis	0.00012	0.000828	CcSEcCtD
Lithium—Arrhythmia—Methylprednisolone—allergic rhinitis	0.00012	0.000827	CcSEcCtD
Lithium—Vomiting—Montelukast—allergic rhinitis	0.000119	0.000824	CcSEcCtD
Lithium—Rash—Montelukast—allergic rhinitis	0.000118	0.000817	CcSEcCtD
Lithium—Dermatitis—Montelukast—allergic rhinitis	0.000118	0.000816	CcSEcCtD
Lithium—GSK3A—Adaptive Immune System—HLA-DQB1—allergic rhinitis	0.000118	0.00572	CbGpPWpGaD
Lithium—Headache—Montelukast—allergic rhinitis	0.000117	0.000812	CcSEcCtD
Lithium—GSK3A—Signaling Pathways—PTGDR2—allergic rhinitis	0.000117	0.00566	CbGpPWpGaD
Lithium—Angioedema—Prednisolone—allergic rhinitis	0.000116	0.000802	CcSEcCtD
Lithium—GSK3A—Immune System—HLA-G—allergic rhinitis	0.000114	0.00556	CbGpPWpGaD
Lithium—Dysgeusia—Triamcinolone—allergic rhinitis	0.000114	0.000791	CcSEcCtD
Lithium—GSK3A—Integrated Pancreatic Cancer Pathway—TGFB1—allergic rhinitis	0.000114	0.00556	CbGpPWpGaD
Lithium—Vertigo—Prednisolone—allergic rhinitis	0.000114	0.000789	CcSEcCtD
Lithium—Syncope—Prednisolone—allergic rhinitis	0.000114	0.000787	CcSEcCtD
Lithium—Angioedema—Hydrocortisone—allergic rhinitis	0.000113	0.000784	CcSEcCtD
Lithium—GSK3B—Downstream signaling events of B Cell Receptor (BCR)—NFKB1—allergic rhinitis	0.000113	0.00549	CbGpPWpGaD
Lithium—Loss of consciousness—Prednisolone—allergic rhinitis	0.000112	0.000772	CcSEcCtD
Lithium—Vertigo—Hydrocortisone—allergic rhinitis	0.000111	0.000771	CcSEcCtD
Lithium—Nausea—Montelukast—allergic rhinitis	0.000111	0.00077	CcSEcCtD
Lithium—Syncope—Hydrocortisone—allergic rhinitis	0.000111	0.000769	CcSEcCtD
Lithium—Convulsion—Prednisolone—allergic rhinitis	0.00011	0.000761	CcSEcCtD
Lithium—Loss of consciousness—Hydrocortisone—allergic rhinitis	0.000109	0.000754	CcSEcCtD
Lithium—Arrhythmia—Betamethasone—allergic rhinitis	0.000109	0.000752	CcSEcCtD
Lithium—Arrhythmia—Dexamethasone—allergic rhinitis	0.000109	0.000752	CcSEcCtD
Lithium—GSK3B—Fc epsilon receptor (FCERI) signaling—NFKB1—allergic rhinitis	0.000108	0.00524	CbGpPWpGaD
Lithium—Alopecia—Dexamethasone—allergic rhinitis	0.000108	0.000744	CcSEcCtD
Lithium—Alopecia—Betamethasone—allergic rhinitis	0.000108	0.000744	CcSEcCtD
Lithium—Convulsion—Hydrocortisone—allergic rhinitis	0.000107	0.000743	CcSEcCtD
Lithium—Discomfort—Prednisolone—allergic rhinitis	0.000107	0.000739	CcSEcCtD
Lithium—Angioedema—Triamcinolone—allergic rhinitis	0.000107	0.000738	CcSEcCtD
Lithium—Angioedema—Methylprednisolone—allergic rhinitis	0.000106	0.000736	CcSEcCtD
Lithium—Vertigo—Triamcinolone—allergic rhinitis	0.000105	0.000726	CcSEcCtD
Lithium—Syncope—Triamcinolone—allergic rhinitis	0.000105	0.000724	CcSEcCtD
Lithium—Vertigo—Methylprednisolone—allergic rhinitis	0.000105	0.000724	CcSEcCtD
Lithium—Syncope—Methylprednisolone—allergic rhinitis	0.000105	0.000723	CcSEcCtD
Lithium—Discomfort—Hydrocortisone—allergic rhinitis	0.000104	0.000721	CcSEcCtD
Lithium—Oedema—Prednisolone—allergic rhinitis	0.000104	0.000717	CcSEcCtD
Lithium—Loss of consciousness—Triamcinolone—allergic rhinitis	0.000103	0.00071	CcSEcCtD
Lithium—Loss of consciousness—Methylprednisolone—allergic rhinitis	0.000102	0.000708	CcSEcCtD
Lithium—Shock—Prednisolone—allergic rhinitis	0.000102	0.000705	CcSEcCtD
Lithium—Oedema—Hydrocortisone—allergic rhinitis	0.000101	0.0007	CcSEcCtD
Lithium—Convulsion—Triamcinolone—allergic rhinitis	0.000101	0.0007	CcSEcCtD
Lithium—Convulsion—Methylprednisolone—allergic rhinitis	0.000101	0.000698	CcSEcCtD
Lithium—GSK3B—B Cell Activation—NFKB1—allergic rhinitis	9.97e-05	0.00485	CbGpPWpGaD
Lithium—Shock—Hydrocortisone—allergic rhinitis	9.96e-05	0.000689	CcSEcCtD
Lithium—GSK3A—Signaling by NGF—NFKB1—allergic rhinitis	9.94e-05	0.00483	CbGpPWpGaD
Lithium—Arthralgia—Methylprednisolone—allergic rhinitis	9.92e-05	0.000686	CcSEcCtD
Lithium—Discomfort—Triamcinolone—allergic rhinitis	9.83e-05	0.000679	CcSEcCtD
Lithium—Discomfort—Methylprednisolone—allergic rhinitis	9.8e-05	0.000678	CcSEcCtD
Lithium—Dry mouth—Triamcinolone—allergic rhinitis	9.73e-05	0.000672	CcSEcCtD
Lithium—Angioedema—Dexamethasone—allergic rhinitis	9.68e-05	0.000669	CcSEcCtD
Lithium—Angioedema—Betamethasone—allergic rhinitis	9.68e-05	0.000669	CcSEcCtD
Lithium—Anorexia—Hydrocortisone—allergic rhinitis	9.65e-05	0.000667	CcSEcCtD
Lithium—Confusional state—Methylprednisolone—allergic rhinitis	9.59e-05	0.000663	CcSEcCtD
Lithium—Oedema—Triamcinolone—allergic rhinitis	9.53e-05	0.000659	CcSEcCtD
Lithium—Vertigo—Betamethasone—allergic rhinitis	9.52e-05	0.000658	CcSEcCtD
Lithium—Vertigo—Dexamethasone—allergic rhinitis	9.52e-05	0.000658	CcSEcCtD
Lithium—Syncope—Betamethasone—allergic rhinitis	9.5e-05	0.000657	CcSEcCtD
Lithium—Syncope—Dexamethasone—allergic rhinitis	9.5e-05	0.000657	CcSEcCtD
Lithium—Hypotension—Hydrocortisone—allergic rhinitis	9.46e-05	0.000654	CcSEcCtD
Lithium—Shock—Triamcinolone—allergic rhinitis	9.38e-05	0.000648	CcSEcCtD
Lithium—Shock—Methylprednisolone—allergic rhinitis	9.36e-05	0.000647	CcSEcCtD
Lithium—GSK3B—Developmental Biology—SMAD3—allergic rhinitis	9.33e-05	0.00453	CbGpPWpGaD
Lithium—Loss of consciousness—Betamethasone—allergic rhinitis	9.32e-05	0.000644	CcSEcCtD
Lithium—Loss of consciousness—Dexamethasone—allergic rhinitis	9.32e-05	0.000644	CcSEcCtD
Lithium—GSK3A—Immune System—IL5—allergic rhinitis	9.23e-05	0.00448	CbGpPWpGaD
Lithium—Musculoskeletal discomfort—Hydrocortisone—allergic rhinitis	9.22e-05	0.000638	CcSEcCtD
Lithium—Convulsion—Dexamethasone—allergic rhinitis	9.18e-05	0.000635	CcSEcCtD
Lithium—Convulsion—Betamethasone—allergic rhinitis	9.18e-05	0.000635	CcSEcCtD
Lithium—GSK3A—Signaling Pathways—CYSLTR1—allergic rhinitis	9.14e-05	0.00444	CbGpPWpGaD
Lithium—Discomfort—Dexamethasone—allergic rhinitis	8.92e-05	0.000616	CcSEcCtD
Lithium—Discomfort—Betamethasone—allergic rhinitis	8.92e-05	0.000616	CcSEcCtD
Lithium—Dyspepsia—Hydrocortisone—allergic rhinitis	8.91e-05	0.000616	CcSEcCtD
Lithium—Hypotension—Methylprednisolone—allergic rhinitis	8.89e-05	0.000614	CcSEcCtD
Lithium—GSK3A—Signaling Pathways—CCL11—allergic rhinitis	8.83e-05	0.00429	CbGpPWpGaD
Lithium—Decreased appetite—Hydrocortisone—allergic rhinitis	8.8e-05	0.000608	CcSEcCtD
Lithium—Fatigue—Hydrocortisone—allergic rhinitis	8.73e-05	0.000603	CcSEcCtD
Lithium—GSK3B—Adaptive Immune System—HLA-DQB1—allergic rhinitis	8.7e-05	0.00423	CbGpPWpGaD
Lithium—Musculoskeletal discomfort—Triamcinolone—allergic rhinitis	8.69e-05	0.0006	CcSEcCtD
Lithium—Musculoskeletal discomfort—Methylprednisolone—allergic rhinitis	8.67e-05	0.000599	CcSEcCtD
Lithium—Oedema—Dexamethasone—allergic rhinitis	8.65e-05	0.000598	CcSEcCtD
Lithium—Oedema—Betamethasone—allergic rhinitis	8.65e-05	0.000598	CcSEcCtD
Lithium—GSK3B—Signaling Pathways—PTGDR2—allergic rhinitis	8.61e-05	0.00419	CbGpPWpGaD
Lithium—GSK3A—Adaptive Immune System—ICAM1—allergic rhinitis	8.6e-05	0.00418	CbGpPWpGaD
Lithium—Feeling abnormal—Prednisolone—allergic rhinitis	8.54e-05	0.000591	CcSEcCtD
Lithium—Shock—Betamethasone—allergic rhinitis	8.51e-05	0.000588	CcSEcCtD
Lithium—Shock—Dexamethasone—allergic rhinitis	8.51e-05	0.000588	CcSEcCtD
Lithium—GSK3B—Immune System—HLA-G—allergic rhinitis	8.46e-05	0.00411	CbGpPWpGaD
Lithium—Dyspepsia—Triamcinolone—allergic rhinitis	8.39e-05	0.00058	CcSEcCtD
Lithium—Dyspepsia—Methylprednisolone—allergic rhinitis	8.37e-05	0.000579	CcSEcCtD
Lithium—Feeling abnormal—Hydrocortisone—allergic rhinitis	8.34e-05	0.000577	CcSEcCtD
Lithium—Gastrointestinal pain—Hydrocortisone—allergic rhinitis	8.28e-05	0.000572	CcSEcCtD
Lithium—Anorexia—Betamethasone—allergic rhinitis	8.25e-05	0.00057	CcSEcCtD
Lithium—Anorexia—Dexamethasone—allergic rhinitis	8.25e-05	0.00057	CcSEcCtD
Lithium—Fatigue—Triamcinolone—allergic rhinitis	8.22e-05	0.000568	CcSEcCtD
Lithium—Fatigue—Methylprednisolone—allergic rhinitis	8.2e-05	0.000567	CcSEcCtD
Lithium—Hypotension—Dexamethasone—allergic rhinitis	8.08e-05	0.000559	CcSEcCtD
Lithium—Hypotension—Betamethasone—allergic rhinitis	8.08e-05	0.000559	CcSEcCtD
Lithium—Abdominal pain—Hydrocortisone—allergic rhinitis	8e-05	0.000553	CcSEcCtD
Lithium—Body temperature increased—Hydrocortisone—allergic rhinitis	8e-05	0.000553	CcSEcCtD
Lithium—Musculoskeletal discomfort—Betamethasone—allergic rhinitis	7.88e-05	0.000545	CcSEcCtD
Lithium—Musculoskeletal discomfort—Dexamethasone—allergic rhinitis	7.88e-05	0.000545	CcSEcCtD
Lithium—Feeling abnormal—Triamcinolone—allergic rhinitis	7.86e-05	0.000543	CcSEcCtD
Lithium—Feeling abnormal—Methylprednisolone—allergic rhinitis	7.84e-05	0.000542	CcSEcCtD
Lithium—GSK3B—Cellular responses to stress—NFKB1—allergic rhinitis	7.83e-05	0.00381	CbGpPWpGaD
Lithium—Gastrointestinal pain—Methylprednisolone—allergic rhinitis	7.78e-05	0.000538	CcSEcCtD
Lithium—Dyspepsia—Betamethasone—allergic rhinitis	7.61e-05	0.000526	CcSEcCtD
Lithium—Dyspepsia—Dexamethasone—allergic rhinitis	7.61e-05	0.000526	CcSEcCtD
Lithium—Body temperature increased—Triamcinolone—allergic rhinitis	7.54e-05	0.000521	CcSEcCtD
Lithium—Abdominal pain—Methylprednisolone—allergic rhinitis	7.52e-05	0.00052	CcSEcCtD
Lithium—Decreased appetite—Dexamethasone—allergic rhinitis	7.52e-05	0.00052	CcSEcCtD
Lithium—Decreased appetite—Betamethasone—allergic rhinitis	7.52e-05	0.00052	CcSEcCtD
Lithium—Fatigue—Dexamethasone—allergic rhinitis	7.46e-05	0.000516	CcSEcCtD
Lithium—Fatigue—Betamethasone—allergic rhinitis	7.46e-05	0.000516	CcSEcCtD
Lithium—GSK3B—Signaling by NGF—NFKB1—allergic rhinitis	7.34e-05	0.00357	CbGpPWpGaD
Lithium—Asthenia—Hydrocortisone—allergic rhinitis	7.26e-05	0.000502	CcSEcCtD
Lithium—GSK3A—Immune System—HLA-DQB1—allergic rhinitis	7.14e-05	0.00347	CbGpPWpGaD
Lithium—Feeling abnormal—Betamethasone—allergic rhinitis	7.13e-05	0.000493	CcSEcCtD
Lithium—Feeling abnormal—Dexamethasone—allergic rhinitis	7.13e-05	0.000493	CcSEcCtD
Lithium—Gastrointestinal pain—Dexamethasone—allergic rhinitis	7.07e-05	0.000489	CcSEcCtD
Lithium—Gastrointestinal pain—Betamethasone—allergic rhinitis	7.07e-05	0.000489	CcSEcCtD
Lithium—Diarrhoea—Hydrocortisone—allergic rhinitis	6.93e-05	0.000479	CcSEcCtD
Lithium—Dizziness—Prednisolone—allergic rhinitis	6.86e-05	0.000474	CcSEcCtD
Lithium—Asthenia—Triamcinolone—allergic rhinitis	6.84e-05	0.000473	CcSEcCtD
Lithium—Abdominal pain—Dexamethasone—allergic rhinitis	6.84e-05	0.000473	CcSEcCtD
Lithium—Body temperature increased—Dexamethasone—allergic rhinitis	6.84e-05	0.000473	CcSEcCtD
Lithium—Abdominal pain—Betamethasone—allergic rhinitis	6.84e-05	0.000473	CcSEcCtD
Lithium—Body temperature increased—Betamethasone—allergic rhinitis	6.84e-05	0.000473	CcSEcCtD
Lithium—Asthenia—Methylprednisolone—allergic rhinitis	6.82e-05	0.000472	CcSEcCtD
Lithium—GSK3B—Immune System—IL5—allergic rhinitis	6.82e-05	0.00331	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—CYSLTR1—allergic rhinitis	6.76e-05	0.00328	CbGpPWpGaD
Lithium—Dizziness—Hydrocortisone—allergic rhinitis	6.7e-05	0.000463	CcSEcCtD
Lithium—GSK3A—Innate Immune System—CD4—allergic rhinitis	6.58e-05	0.0032	CbGpPWpGaD
Lithium—Rash—Prednisolone—allergic rhinitis	6.54e-05	0.000452	CcSEcCtD
Lithium—Dermatitis—Prednisolone—allergic rhinitis	6.53e-05	0.000451	CcSEcCtD
Lithium—GSK3B—Signaling Pathways—CCL11—allergic rhinitis	6.53e-05	0.00317	CbGpPWpGaD
Lithium—Diarrhoea—Methylprednisolone—allergic rhinitis	6.51e-05	0.00045	CcSEcCtD
Lithium—Headache—Prednisolone—allergic rhinitis	6.49e-05	0.000449	CcSEcCtD
Lithium—Vomiting—Hydrocortisone—allergic rhinitis	6.44e-05	0.000445	CcSEcCtD
Lithium—GSK3A—Signaling Pathways—TAC1—allergic rhinitis	6.42e-05	0.00312	CbGpPWpGaD
Lithium—Rash—Hydrocortisone—allergic rhinitis	6.38e-05	0.000441	CcSEcCtD
Lithium—Dermatitis—Hydrocortisone—allergic rhinitis	6.38e-05	0.000441	CcSEcCtD
Lithium—GSK3B—Adaptive Immune System—ICAM1—allergic rhinitis	6.35e-05	0.00309	CbGpPWpGaD
Lithium—Headache—Hydrocortisone—allergic rhinitis	6.34e-05	0.000438	CcSEcCtD
Lithium—GSK3A—Adaptive Immune System—CD4—allergic rhinitis	6.32e-05	0.00307	CbGpPWpGaD
Lithium—Dizziness—Triamcinolone—allergic rhinitis	6.3e-05	0.000436	CcSEcCtD
Lithium—Dizziness—Methylprednisolone—allergic rhinitis	6.29e-05	0.000435	CcSEcCtD
Lithium—Asthenia—Betamethasone—allergic rhinitis	6.21e-05	0.000429	CcSEcCtD
Lithium—Asthenia—Dexamethasone—allergic rhinitis	6.21e-05	0.000429	CcSEcCtD
Lithium—Nausea—Prednisolone—allergic rhinitis	6.16e-05	0.000426	CcSEcCtD
Lithium—Vomiting—Triamcinolone—allergic rhinitis	6.06e-05	0.000419	CcSEcCtD
Lithium—Vomiting—Methylprednisolone—allergic rhinitis	6.05e-05	0.000418	CcSEcCtD
Lithium—Nausea—Hydrocortisone—allergic rhinitis	6.01e-05	0.000416	CcSEcCtD
Lithium—Rash—Triamcinolone—allergic rhinitis	6.01e-05	0.000416	CcSEcCtD
Lithium—Dermatitis—Triamcinolone—allergic rhinitis	6.01e-05	0.000415	CcSEcCtD
Lithium—Rash—Methylprednisolone—allergic rhinitis	6e-05	0.000415	CcSEcCtD
Lithium—GSK3A—Disease—SMAD3—allergic rhinitis	6e-05	0.00291	CbGpPWpGaD
Lithium—Dermatitis—Methylprednisolone—allergic rhinitis	5.99e-05	0.000414	CcSEcCtD
Lithium—Headache—Triamcinolone—allergic rhinitis	5.97e-05	0.000413	CcSEcCtD
Lithium—GSK3A—Signaling Pathways—IL5—allergic rhinitis	5.97e-05	0.0029	CbGpPWpGaD
Lithium—Headache—Methylprednisolone—allergic rhinitis	5.96e-05	0.000412	CcSEcCtD
Lithium—Diarrhoea—Betamethasone—allergic rhinitis	5.92e-05	0.000409	CcSEcCtD
Lithium—Diarrhoea—Dexamethasone—allergic rhinitis	5.92e-05	0.000409	CcSEcCtD
Lithium—Dizziness—Betamethasone—allergic rhinitis	5.72e-05	0.000395	CcSEcCtD
Lithium—Dizziness—Dexamethasone—allergic rhinitis	5.72e-05	0.000395	CcSEcCtD
Lithium—GSK3A—Innate Immune System—NFKB1—allergic rhinitis	5.67e-05	0.00275	CbGpPWpGaD
Lithium—Nausea—Triamcinolone—allergic rhinitis	5.66e-05	0.000391	CcSEcCtD
Lithium—Nausea—Methylprednisolone—allergic rhinitis	5.65e-05	0.000391	CcSEcCtD
Lithium—Vomiting—Dexamethasone—allergic rhinitis	5.5e-05	0.00038	CcSEcCtD
Lithium—Vomiting—Betamethasone—allergic rhinitis	5.5e-05	0.00038	CcSEcCtD
Lithium—Rash—Betamethasone—allergic rhinitis	5.45e-05	0.000377	CcSEcCtD
Lithium—Rash—Dexamethasone—allergic rhinitis	5.45e-05	0.000377	CcSEcCtD
Lithium—Dermatitis—Dexamethasone—allergic rhinitis	5.45e-05	0.000377	CcSEcCtD
Lithium—Dermatitis—Betamethasone—allergic rhinitis	5.45e-05	0.000377	CcSEcCtD
Lithium—GSK3A—Adaptive Immune System—NFKB1—allergic rhinitis	5.44e-05	0.00265	CbGpPWpGaD
Lithium—Headache—Betamethasone—allergic rhinitis	5.42e-05	0.000375	CcSEcCtD
Lithium—Headache—Dexamethasone—allergic rhinitis	5.42e-05	0.000375	CcSEcCtD
Lithium—GSK3B—Immune System—HLA-DQB1—allergic rhinitis	5.28e-05	0.00257	CbGpPWpGaD
Lithium—GSK3A—Immune System—ICAM1—allergic rhinitis	5.21e-05	0.00253	CbGpPWpGaD
Lithium—Nausea—Dexamethasone—allergic rhinitis	5.14e-05	0.000355	CcSEcCtD
Lithium—Nausea—Betamethasone—allergic rhinitis	5.14e-05	0.000355	CcSEcCtD
Lithium—GSK3B—Innate Immune System—CD4—allergic rhinitis	4.86e-05	0.00236	CbGpPWpGaD
Lithium—GSK3B—Developmental Biology—NFKB1—allergic rhinitis	4.74e-05	0.0023	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—TAC1—allergic rhinitis	4.74e-05	0.0023	CbGpPWpGaD
Lithium—GSK3B—Adaptive Immune System—CD4—allergic rhinitis	4.67e-05	0.00227	CbGpPWpGaD
Lithium—GSK3B—Disease—SMAD3—allergic rhinitis	4.43e-05	0.00215	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—IL5—allergic rhinitis	4.41e-05	0.00214	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—SMAD3—allergic rhinitis	4.2e-05	0.00204	CbGpPWpGaD
Lithium—GSK3B—Innate Immune System—NFKB1—allergic rhinitis	4.19e-05	0.00204	CbGpPWpGaD
Lithium—GSK3B—Adaptive Immune System—NFKB1—allergic rhinitis	4.02e-05	0.00195	CbGpPWpGaD
Lithium—GSK3B—Developmental Biology—TGFB1—allergic rhinitis	3.95e-05	0.00192	CbGpPWpGaD
Lithium—GSK3B—Immune System—ICAM1—allergic rhinitis	3.85e-05	0.00187	CbGpPWpGaD
Lithium—GSK3A—Immune System—CD4—allergic rhinitis	3.83e-05	0.00186	CbGpPWpGaD
Lithium—GSK3A—Disease—CD4—allergic rhinitis	3.54e-05	0.00172	CbGpPWpGaD
Lithium—GSK3A—Immune System—NFKB1—allergic rhinitis	3.3e-05	0.0016	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—SMAD3—allergic rhinitis	3.1e-05	0.00151	CbGpPWpGaD
Lithium—GSK3B—Immune System—CD4—allergic rhinitis	2.83e-05	0.00138	CbGpPWpGaD
Lithium—GSK3B—Disease—CD4—allergic rhinitis	2.61e-05	0.00127	CbGpPWpGaD
Lithium—GSK3A—Disease—TGFB1—allergic rhinitis	2.54e-05	0.00123	CbGpPWpGaD
Lithium—GSK3B—Immune System—NFKB1—allergic rhinitis	2.44e-05	0.00119	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—NFKB1—allergic rhinitis	2.13e-05	0.00104	CbGpPWpGaD
Lithium—GSK3B—Disease—TGFB1—allergic rhinitis	1.88e-05	0.000912	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—TGFB1—allergic rhinitis	1.78e-05	0.000864	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—NFKB1—allergic rhinitis	1.58e-05	0.000767	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—TGFB1—allergic rhinitis	1.31e-05	0.000639	CbGpPWpGaD
